Prognostic and predictive value of neutrophil-to-lymphocyte ratio (NLR) in previously treated patients with malignant pleural mesothelioma (MPM) enrolled in the NGR015 phase 3 trial
Bulotta, Alessandra, Gregorc, Vanesa, Viganò, Maria G, Rossoni, Gilda, Fontana, Floriana, Ammannati, Cristina, Colombi, Scialini, Lambiase, Antonio, Bordignon, Claudio
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Phase I Study of NGR-hTNF, a Selective Vascular Targeting Agent, in Combination with Cisplatin in Refractory Solid Tumors
GREGORC, Vanesa, DE BRAUD, Filippo G, GHIO, Domenico, SPITALERI, Gianluca, AMMANNATI, Cristina, COLOMBI, Scialini, CALIGARIS-CAPPIO, Federico, LAMBIASE, Antonio, BORDIGNON, Claudio, DE PAS, Tommaso M, SCALAMOGNA, Roberto, CITTERIO, Giovanni, MILANI, Alessandra, BOSELLI, Sabrina, CATANIA, Chiara, DONADONI, Giovanni, ROSSONI, Gilda
Published in Clinical cancer research (01.04.2011)
Published in Clinical cancer research (01.04.2011)
Get full text
Journal Article
Relationships of peripheral blood lymphocyte counts (PBLC) with antitumor activity of NGR-hTNF given in combination with chemotherapy (CT)
Bulotta, Alessandra, Gregorc, Vanesa, Rossoni, Gilda, Todisco, Gabriele, Viganò, Maria Grazia, Ammannati, Cristina, Mazzola, Giulia, Lambiase, Antonio, Bordignon, Claudio
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Impact of treatment-free interval (TFI) and disease control rate (DCR) on survival outcome in relapsed malignant pleural mesothelioma (MPM)
Gregorc, Vanesa, Bulotta, Alessandra, Viganò, Maria Grazia, Ghio, Domenico, Rossoni, Gilda, Sallemi, Claudio, Fontana, Floriana, Ammannati, Cristina, Colombi, Scialini, Lambiase, Antonio, Bordignon, Claudio
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article